<DOC>
	<DOCNO>NCT03009513</DOCNO>
	<brief_summary>An open label , one sequence study investigate pharmacokinetic drug interaction Teneligliptin Glimepiride healthy male subject</brief_summary>
	<brief_title>Teneligliptin-Glimepiride DDI Study</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<criteria>1 . Healthy male adult age 20 45 year 2 . Body weight â‰¥ 50kg , BMI 18 29 kg/m2 screen 3 . Subject agree use medically acceptable doublebarrier method contraception donate sperm first dose 2 month last dose . 4 . Subject give , fully understood , information study , provide voluntary write informed consent participate study agree comply study requirement .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>